中文簡介
分子療法-核酸是一種國際性的、開放獲取的期刊,在核酸療法治療和/或糾正遺傳和獲得性疾病的廣泛領(lǐng)域中,出版高質(zhì)量的基礎(chǔ)、翻譯和臨床研究。研究領(lǐng)域包括但不限于:基于核酸及其衍生物的治療方法的開發(fā)、基于rna的治療方法的載體開發(fā)和設(shè)計、基因修飾劑的應用,包括形成三聚體的寡核苷酸和酶(如鋅指核酸酶)、臨床前目標驗證、安全性/有效性研究和臨床試驗。分子治療-核酸2015影響因子為5.048。
英文簡介
Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048.
近年期刊自引率趨勢圖
JCR分區(qū)
JCR分區(qū)等級 | JCR所屬學科 | 分區(qū) | 影響因子 |
Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | Q1 | 10.183 |
近年期刊影響因子趨勢圖
CiteScore數(shù)值
CiteScore | SJR | SNIP | 學科類別 | 分區(qū) | 排名 | 百分位 |
12.90 | 1.852 | 1.421 | 大類:Pharmacology, Toxicology and Pharmaceutics 小類:Drug Discovery | Q1 | 10 / 154 |
93% |
大類:Pharmacology, Toxicology and Pharmaceutics 小類:Molecular Medicine | Q1 | 15 / 167 |
91% |
相關(guān)醫(yī)學SCI期刊推薦
copyright © m.wangshangbanli.cn, All Rights Reserved
搜論文知識網(wǎng) 冀ICP備15021333號-3